The interleukin-6--174 single nucleotide polymorphism: cervical protein production and the risk of preterm delivery

Am J Obstet Gynecol. 2005 Apr;192(4):1023-7. doi: 10.1016/j.ajog.2005.01.035.

Abstract

Objective: The purpose of this study was to determine the associations between preterm delivery (PTD), cervical fluid interleukin-6 (IL-6) concentration, and the single nucleotide polymorphism at position -174 in the IL-6 gene.

Study design: Cervical fluid samples were obtained from women 23 to 32 weeks' gestation with symptoms of preterm labor. Concentrations of IL-6 were determined by enzyme-linked immunosorbent assay (ELISA). IL-6 genotyping was performed using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique.

Results: One hundred thirty-seven women were enrolled, and complete information was available for 126. Cervical fluid IL-6 concentrations were not elevated in women destined to have a spontaneous PTD ( P = .86). IL-6 -174 genotype was not associated with PTD ( P = .62) or cervical fluid IL-6 concentration ( P = .36). Neonatal IL-6-174 genotype was not associated with PTD or IL-6 concentration.

Conclusion: Cervical fluid concentrations of IL-6 were not elevated in symptomatic women destined to have a spontaneous PTD. The presence of maternal IL-6 -174C was not associated with cervical fluid concentration of IL-6 or risk of PTD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amniotic Fluid / metabolism
  • Base Sequence
  • Biomarkers / analysis
  • Biomarkers / metabolism*
  • Cervix Uteri / metabolism*
  • Cohort Studies
  • Female
  • Genotype
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Interleukin-6 / blood*
  • Interleukin-6 / genetics
  • Molecular Sequence Data
  • Obstetric Labor, Premature / blood*
  • Polymerase Chain Reaction / methods
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide*
  • Pregnancy
  • Pregnancy Outcome*
  • Probability
  • Prospective Studies
  • Risk Assessment
  • Sensitivity and Specificity

Substances

  • Biomarkers
  • Interleukin-6